Directory

>

Peter Chin

avatar

Peter Chin

Sr. Vice President & Head of Late-Stage Clinical Development and Medical Affairs | Denali Therapeutics

South San Francisco, California, United States

View contact details (it's free)

Peter Chin

Summary

Peter Chin is a seasoned executive in the biopharmaceutical industry, currently serving as the Senior Vice President at Denali Therapeutics. With a robust background in clinical development and medical affairs, he has dedicated over two decades to advancing therapies in neurology and other critical therapeutic areas. His expertise spans immunology, oncology, and regulatory submissions, making him a pivotal figure in drug development. Peter's leadership experience is underscored by his roles at major companies like Genentech and Novartis, where he has directed late-stage clinical programs. He holds a Doctor of Medicine from Dartmouth Medical School and a Master of Science in Health Services from UCLA. Peter's commitment to improving patient outcomes is evident in his extensive work in clinical trials and pharmacovigilance. He is also known for fostering innovation in clinical practices, ensuring adherence to good clinical practices (GCP). Outside of his professional life, Peter is passionate about mentoring the next generation of medical professionals and contributing to advancements in healthcare policy.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Sustainability

Organisational experience

Corporate Experience

Peter Chin

Work Experience

company logo

Sr. Vice President & Head of Late-Stage Clinical Development and Medical Affairs at

Denali Therapeutics

October 2021 - Present

company logo

Vice President & Head of Late-Stage Clinical Development and Medical Affairs at

Denali Therapeutics

April 2019 - October 2021

company logo

Group Medical Director for Neuroscience | U.S. Medical Affairs at

Genentech Foundation

August 2016 - March 2019

💼

Principal Medical Director | Roche Global Product Development - Neuroscience at

Roche Global Neuroscience Development

August 2014 - July 2016

company logo

Global Program Medical Director, Executive Director at

Novartis

March 2011 - July 2014

company logo

Medical Director | Roche Global Product Development - Neuroscience at

Genentech Foundation

July 2009 - February 2011

💼

Associate Medical Director | Immunology, Tissue Growth and Repair Development at

Genentech Itgr Development

September 2007 - June 2009

💼

Sr. Health Economist | Health Economics and Outcomes Research at

Genentech Health Economics And Outcomes Research

July 2005 - August 2007

company logo

Robert Wood Johnson Clinical Scholar at

Ucla

July 2003 - June 2005

company logo

Resident Physician, Neurology at

University of Washington, LLC

July 1999 - June 2003

company logo

Research Associate at

Gladstone Institutes

September 1992 - July 1994

Logos provided by Logo.dev

Peter Chin

Education

Dartmouth Medical School, Doctor Of Medicine (Md)

University of California, Berkeley, Bachelor Of Arts (B.A.)

Frequently Asked Questions about Peter Chin

What is Peter Chin email address?

Peter Chin's primary email address is **********@denalitherapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Peter Chin work for?

Peter Chin is a Sr. Vice President & Head of Late-Stage Clinical Development and Medical Affairs at Denali Therapeutics, a company specializing in Commercial physical research.

Where Peter Chin graduated from?

Peter Chin holds a degree in from Dartmouth Medical School.

How can I directly contact Peter Chin?

To contact Peter Chin directly, you can use the email address **********@denalitherapeutics.com. Complete contact information is available upon registration with Muraena.

Who is Peter Chin?

Peter Chin is a seasoned executive in the biopharmaceutical industry, currently serving as the Senior Vice President at Denali Therapeutics. With a robust background in clinical development and medical affairs, he has dedicated over two decades to advancing therapies in neurology and other critical therapeutic areas. His expertise spans immunology, oncology, and regulatory submissions, making him a pivotal figure in drug development. Peter's leadership experience is underscored by his roles at major companies like Genentech and Novartis, where he has directed late-stage clinical programs. He holds a Doctor of Medicine from Dartmouth Medical School and a Master of Science in Health Services from UCLA. Peter's commitment to improving patient outcomes is evident in his extensive work in clinical trials and pharmacovigilance. He is also known for fostering innovation in clinical practices, ensuring adherence to good clinical practices (GCP). Outside of his professional life, Peter is passionate about mentoring the next generation of medical professionals and contributing to advancements in healthcare policy.

Peter`s contact details

mail

**********@denalitherapeutics.com

**********@gene.com

Colleagues

avatar
Sarah Rhodes Martin

VP, US ETV Franchise and Global Product Strategy

avatar
Alexander Schuth

Director Board Of Directors

avatar
Eric Strait

Executive Director, Legal Department

avatar
Anthony Delucchi

Vice President, Technical Operations

avatar
Terry Hudson

Executive Director

avatar
Laura Hansen

Vice President of Investor Relations

avatar
Mitesh Shridhar

Executive Director, Corporate Development

avatar
Leah Frautschy

Vice President, Clinical Manufacturing

avatar
Katie Peng

Board Member

View Contact details (it's free)
Request Profile Removal